Exact Mass: 337.1438

Exact Mass Matches: 337.1438

Found 500 metabolites which its exact mass value is equals to given mass value 337.1438, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Linezolid

N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide

C16H20FN3O4 (337.1438)


Linezolid is only found in individuals that have used or taken this drug. It is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). Linezolid is a synthetic antibacterial agent of the oxazolidinone class of antibiotics. It has in vitro activity against aerobic Gram positive bacteria, certain Gram negative bacteria and anaerobic microorganisms. It selectively inhibits bacterial protein synthesis through binding to sites on the bacterial ribosome and prevents the formation of a functional 70S-initiation complex. Specifically, linezolid binds to a site on the bacterial 23S ribosomal RNA of the 50S subunit and prevents the formation of a functional 70S initiation complex, which is an essential component of the bacterial translation process. The results of time-kill studies have shown linezolid to be bacteriostatic against enterococci and staphylococci. For streptococci, linezolid was found to be bactericidal for the majority of strains. Linezolid is also a reversible, nonselective inhibitor of monoamine oxidase. Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic

   

Olopatadine

2-[(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-5-yl]acetic acid

C21H23NO3 (337.1678)


Used to treat allergic conjunctivitis (itching eyes), olopatadine inhibits the release of histamine from mast cells. It is a relatively selective histamine H1 antagonist that inhibits the in vivo and in vitro type 1 immediate hypersensitivity reaction including inhibition of histamine induced effects on human conjunctival epithelial cells. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents

   

Ligularinine

Platyphylline

C18H27NO5 (337.1889)


   

Bitertanol

Pesticide6_Bitertanol_C20H23N3O2_1-(4-Biphenylyloxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanol

C20H23N3O2 (337.179)


D016573 - Agrochemicals D010575 - Pesticides

   

Kyotorphin

(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C15H23N5O4 (337.175)


Kyotorphin (L-tyrosyl-L-arginine) is a neuroactive dipeptide which plays a role in pain regulation in the brain. It was first isolated from bovine brain by Japanese scientists in 1979. Kyotorphin was named for the site of its discovery, Kyoto, Japan and because of its morphine- (or endorphin-) like analgesic activity. Kyotorphin has an analgesic effect, but it does not interact with the opioid receptors. Instead, it acts by releasing an Met-enkephalin and stabilizing it from degradation. It may also possess properties of neuromediator/neuromodulator. It has been shown that kyotorphin is present in the human cerebrospinal fluid and that it is lower in patients with persistent pain. [HMDB] Kyotorphin (L-tyrosyl-L-arginine) is a neuroactive dipeptide which plays a role in pain regulation in the brain. It was first isolated from bovine brain by Japanese scientists in 1979. Kyotorphin was named for the site of its discovery, Kyoto, Japan and because of its morphine- (or endorphin-) like analgesic activity. Kyotorphin has an analgesic effect, but it does not interact with the opioid receptors. Instead, it acts by releasing an Met-enkephalin and stabilizing it from degradation. It may also possess properties of neuromediator/neuromodulator. It has been shown that kyotorphin is present in the human cerebrospinal fluid and that it is lower in patients with persistent pain. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004723 - Endorphins Kyotorphin is an endogenou neuroactive dipeptide with analgesic properties. Kyotorphin possesses anti-inflammatory and antimicrobial activity. Kyotorphin levels in cerebro-spinal fluid correlate negatively with the progression of neurodegeneration in Alzheimer's Disease patients[1].

   

Indole-3-acetyl-myo-inositol

(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-(1H-indol-3-yl)acetate

C16H19NO7 (337.1161)


1H-Indol-3-ylacetyl-myo-inositol is found in cereals and cereal products. 1H-Indol-3-ylacetyl-myo-inositol is present in Oryza sativa (rice) and Zea mays (corn Present in Oryza sativa (rice) and Zea mays (corn). 1H-Indol-3-ylacetyl-myo-inositol is found in cereals and cereal products, rice, and corn.

   

4-O-(Indole-3-acetyl)-D-glucopyranose

(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-(1H-indol-3-yl)acetate

C16H19NO7 (337.1161)


4-o-(indole-3-acetyl)-d-glucopyranose, also known as indole-3-acetyl-beta-1-D-glucose or B-D-glucopyranose, 1-(1h-indole-3-acetic acid), belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. 4-o-(indole-3-acetyl)-d-glucopyranose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 4-o-(indole-3-acetyl)-d-glucopyranose can be found in corn, which makes 4-o-(indole-3-acetyl)-d-glucopyranose a potential biomarker for the consumption of this food product. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

Streptobiosamine

Streptobiosamine

C13H23NO9 (337.1373)


An amino disaccharide that is a 2-deoxy-2-(methylamino)-alpha-L-glucopyranose ring joined to a L-lyxose with a formyl substituent at position 3.

   

Nemorensine

C(16a)-Homo-21-norsenecionan-11,16a-dione, 12,15-epoxy-1,2,15,20-tetrahydro-, (1alpha,12R,15R)-

C18H27NO5 (337.1889)


   

Sarracine

7-Angelyl-9-sarracinylplatynecine

C18H27NO5 (337.1889)


   
   

Ficine

4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-(1-methyl-2-pyrrolidinyl)-2-phenyl-, (-)-

C20H19NO4 (337.1314)


   

Isoficine

4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-(1-methyl-2-pyrrolidinyl)-2-phenyl-

C20H19NO4 (337.1314)


   

Talampanel

Talampanel

C19H19N3O3 (337.1426)


C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Same as: D02696 Talampanel (LY300164) is an orally and selective α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor antagonis with anti-seizure activity[1]. Talampanel (IVAX) has neuroprotective effects in rodent stroke models[2]. Talampanel attenuates caspase-3 dependent apoptosis in mouse brain[2].

   
   

fuchsin basic

Fuchsine base monohydrochloride

C20H20ClN3 (337.1346)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

Lambertine

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,15,17,19-heptaene

C20H19NO4 (337.1314)


Lambertine is an alkaloid. Dihydroberberine is a natural product found in Thalictrum foliolosum, Berberis vulgaris, and other organisms with data available. Lambertine is found in fruits. Lambertine is an alkaloid from Berberis vulgaris (barberry). Alkaloid from Berberis vulgaris (barberry). Lambertine is found in tea and fruits.

   

Junosidine

2,11-Dihydro-5-hydroxy-10-methoxy-2,2,11-trimethyl-6H-pyrano[3,2-b]acridin-6-one, 9ci

C20H19NO4 (337.1314)


Junosidine is a member of the class of compounds known as acridones. Acridones are acridines containing a ketone group attached to the C9 carbon atom of the acridine moiety. Junosidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Junosidine is an alkaloid that has been found in the root bark of Citrus junos (yuzu).

   

5-Methoxynoracronycine

11-hydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one

C20H19NO4 (337.1314)


5-Methoxynoracronycine is found in citrus. 5-Methoxynoracronycine is an alkaloid from the bark of Citrus junos (yuzu

   

3,6-Ditigloyloxytropan-7-ol

7-Hydroxy-8-methyl-3-{[(2E)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2E)-2-methylbut-2-enoic acid

C18H27NO5 (337.1889)


3,6-Ditigloyloxytropan-7-ol is found in fruits. 3,6-Ditigloyloxytropan-7-ol is an alkaloid present in Cyphomandra betacea (tree tomato

   

Arginyltyrosine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H23N5O4 (337.175)


Arginyltyrosine is a dipeptide composed of arginine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tyrosyl-Arginine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-5-carbamimidamidopentanoate

C15H23N5O4 (337.175)


Tyrosyl-Arginine is a dipeptide composed of tyrosine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

4-O-alpha-D-Galactopyranosylcalystegine B2

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,3-triol

C13H23NO9 (337.1373)


4-O-alpha-D-Galactopyranosylcalystegine B2 is found in fruits. 4-O-alpha-D-Galactopyranosylcalystegine B2 is an alkaloid from the fruit of Morus alba (white mulberry). Alkaloid from the fruit of Morus alba (white mulberry). 4-O-alpha-D-Galactopyranosylcalystegine B2 is found in fruits.

   

6-oxo-famciclovir

2-[(acetyloxy)methyl]-4-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)butyl acetate

C14H19N5O5 (337.1386)


6-oxo-famciclovir is a metabolite of famciclovir. Famciclovir is a guanine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir. On August 24, 2007, the United States Food and Drug Administration approved the first generic version of famciclovir. (Wikipedia)

   

Posiphen

1-({1,3a,8-trimethyl-1H,2H,3H,3ah,8H,8ah-pyrrolo[2,3-b]indol-5-yl}oxy)-N-phenylmethanimidate

C20H23N3O2 (337.179)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors

   

4-(2-((7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino)ethyl)phenol

4-(2-{[7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino}ethyl)phenol

C16H15N7O2 (337.1287)


ZM241385 is a potent, high affinity and selective adenosine A2a receptor (A2AR) antagonist with a Ki value of 1.4 nM[1][2][3].

   

3-Quinuclidinyl benzilate

1-azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2-diphenylacetate

C21H23NO3 (337.1678)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

4-Methylumbelliferylguanidinobenzoate

4-methyl-2-oxo-2H-chromen-7-yl 4-[(diaminomethylidene)amino]benzoate

C18H15N3O4 (337.1063)


   

Furylacryloylalanyllysine

6-Amino-2-[(2-{[3-(furan-2-yl)-1-hydroxyprop-2-en-1-ylidene]amino}-1-hydroxypropylidene)amino]hexanoate

C16H23N3O5 (337.1638)


   

3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide

3-(4-tert-butylphenyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)prop-2-enamide

C21H23NO3 (337.1678)


   

Benin

N-(2-Ethoxy-2-oxoethyl)-5-(9H-purin-6-ylsulphanyl)pentanimidic acid

C14H19N5O3S (337.1209)


   

2-[11-[3-(Dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid

2-{2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3(8),4,6,11,13-hexaen-5-yl}acetic acid

C21H23NO3 (337.1678)


   

1-(4-Aminophenyl)-3-acetyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine

1-[10-(4-aminophenyl)-13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0^{3,7}]tetradeca-1,3(7),8,10-tetraen-12-yl]ethan-1-one

C19H19N3O3 (337.1426)


   

H-D-Tyr-val-gly-OH

2-[(2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylbutylidene)amino]acetate

C16H23N3O5 (337.1638)


   

N-(p-Amylcinnamoyl)anthranilic acid

2-[3-(4-pentylphenyl)prop-2-enamido]benzoic acid

C21H23NO3 (337.1678)


   

N-Desmethyladinazolam

({12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methyl)(methyl)amine

C18H16ClN5 (337.1094)


   

N(6)-Monobutyryladenosine

N-{9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}butanamide

C14H19N5O5 (337.1386)


   

Oclacitinib

N-Methyl-1-{4-[methyl({7h-pyrrolo[2,3-D]pyrimidin-4-yl})amino]cyclohexyl}methanesulphonamide

C15H23N5O2S (337.1572)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor

   

Pargeverine

2-(Dimethylamino)ethyl 2,2-diphenyl-2-(prop-2-yn-1-yloxy)acetic acid

C21H23NO3 (337.1678)


   

Propanidid

Propyl 2-[4-[2-(diethylamino)-2-oxoethoxy]-3-methoxyphenyl]acetic acid

C18H27NO5 (337.1889)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Satigrel

4-Cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid

C20H19NO4 (337.1314)


   

1-Azabicyclo[2.2.2]octan-2-yl 2-hydroxy-2,2-diphenylacetate

1-Azabicyclo[2.2.2]octan-2-yl 2-hydroxy-2,2-diphenylacetic acid

C21H23NO3 (337.1678)


   

Ractopamine hydrochloride

4-Hydroxy-alpha-(((3-(4-hydroxyphenyl)-1-methylpropyl)amino)methyl)benzenemethanol

C18H24ClNO3 (337.1445)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Leanness enhancer for pigs. Approved for use in the USA

   

indole-3-acetyl-tyrosine

4-(2-Carboxy-2-{[1-hydroxy-2-(1H-indol-3-yl)ethylidene]amino}ethyl)benzen-1-olic acid

C19H17N2O4- (337.1188)


Indole-3-acetyl-tyrosine is also known as iaa-tyr. Indole-3-acetyl-tyrosine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-tyrosine can be found in a number of food items such as lupine, other cereal product, poppy, and burbot, which makes indole-3-acetyl-tyrosine a potential biomarker for the consumption of these food products.

   

indole-3-acetyl-beta-4-D-glucose

4,5,6-Trihydroxy-2-(hydroxymethyl)oxan-3-yl 2-(1H-indol-3-yl)acetic acid

C16H19NO7 (337.1161)


Indole-3-acetyl-beta-4-d-glucose belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetyl-beta-4-d-glucose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Indole-3-acetyl-beta-4-d-glucose can be found in a number of food items such as tamarind, black-eyed pea, sweet potato, and sourdough, which makes indole-3-acetyl-beta-4-d-glucose a potential biomarker for the consumption of these food products.

   

indole-3-acetyl-beta-6-D-glucose

(3,4,5,6-Tetrahydroxyoxan-2-yl)methyl 2-(1H-indol-3-yl)acetic acid

C16H19NO7 (337.1161)


Indole-3-acetyl-beta-6-d-glucose belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetyl-beta-6-d-glucose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Indole-3-acetyl-beta-6-d-glucose can be found in a number of food items such as apple, coconut, black mulberry, and american butterfish, which makes indole-3-acetyl-beta-6-d-glucose a potential biomarker for the consumption of these food products.

   

Voxelotor

2-hydroxy-6-({2-[1-(propan-2-yl)-1H-pyrazol-5-yl]pyridin-3-yl}methoxy)benzaldehyde

C19H19N3O3 (337.1426)


   
   
   

Murrayamine I

Murrayamine I

C20H19NO4 (337.1314)


   
   

Dehydrocrebanine

Dehydrocrebanine

C20H19NO4 (337.1314)


   

Dehydrodicentrine

5H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline, 6,7-dihydro-10,11-dimethoxy-7-Methyl-

C20H19NO4 (337.1314)


   

AKOS000277823

AKOS000277823

C20H19NO4 (337.1314)


   

3alpha-(3,4,5-Trimethoxybenzoyloxy)nortropan-6beta-ol

3alpha-(3,4,5-Trimethoxybenzoyloxy)nortropan-6beta-ol

C17H23NO6 (337.1525)


   

Sinomendine

Sinomendine

C20H19NO4 (337.1314)


An aporphine alkaloid that is 7-methyldibenzo[de,g]quinolin-7-ol carrying three additional methoxy substituents at positions 2, 8 and 9.

   

Tuberospironine

Tuberospironine

C18H27NO5 (337.1889)


   

Dehydronantenine

Dehydronantenine

C20H19NO4 (337.1314)


   

6-Hydroxycroomine

6alpha-Hydroxycroomine

C18H27NO5 (337.1889)


   

(Indole-3-acetyl)-glucan

beta-(1-4)-Cellulosic glucan(7 to 50 glucose units

C16H19NO7 (337.1161)


   

N-Acetylxylopine

N-Acetylxylopine

C20H19NO4 (337.1314)


   
   

Dihydroneoascorbigen

Dihydroneoascorbigen

C16H19NO7 (337.1161)


   

Maybridge1_005164

Maybridge1_005164

C19H19N3OS (337.1249)


   
   
   
   
   
   

3,9,10-trimethoxy-5,6-dihydroisoquinolin[2,1-b]isoquinolin-7-ium-2-olate

3,9,10-trimethoxy-5,6-dihydroisoquinolin[2,1-b]isoquinolin-7-ium-2-olate

C20H19NO4 (337.1314)


   
   

SCHEMBL22015730

SCHEMBL22015730

C20H19NO4 (337.1314)


   

3alpha-(E)-4-hydroxysenecioyloxy-6beta-senecioyloxytropane

3alpha-(E)-4-hydroxysenecioyloxy-6beta-senecioyloxytropane

C18H27NO5 (337.1889)


   

2-O-Methyl-b-D-N-acetylneuraminic acid methyl ester

2-O-Methyl-b-D-N-acetylneuraminic acid methyl ester

C13H23NO9 (337.1373)


   

SCHEMBL4265170

SCHEMBL4265170

C13H23NO9 (337.1373)


   

(Xi)-beta-D-Glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitril|(Xi)-beta-D-glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitrile

(Xi)-beta-D-Glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitril|(Xi)-beta-D-glucopyranosyloxy-(4-isopropyl-phenyl)-acetonitrile

C17H23NO6 (337.1525)


   

(-)-N-Acetylnorstephalagine|N-Acetylnorstephalagin|N-acetylnorstephalagine

(-)-N-Acetylnorstephalagine|N-Acetylnorstephalagin|N-acetylnorstephalagine

C20H19NO4 (337.1314)


   

1-O-beta-D-glucopyranosyl-5-deoxyadenophorine|1-O-beta-D-glucopyranosyladenophorine

1-O-beta-D-glucopyranosyl-5-deoxyadenophorine|1-O-beta-D-glucopyranosyladenophorine

C14H27NO8 (337.1737)


   

4-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-5-oxo-5-phenylmethoxypentanoic acid

4-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-5-oxo-5-phenylmethoxypentanoic acid

C17H23NO6 (337.1525)


   

(+)-N-acetylnornuciferine

(+)-N-acetylnornuciferine

C20H19NO4 (337.1314)


   
   
   
   
   

SCHEMBL17023918

SCHEMBL17023918

C16H19NO7 (337.1161)


   

2-O-Indolacetyl-myo-inositol

2-O-Indolacetyl-myo-inositol

C16H19NO7 (337.1161)


   

(2R)-beta-D-(6-O-acetyl)-glucosyl-2-phenylacetonitrile|peregrinumcin A

(2R)-beta-D-(6-O-acetyl)-glucosyl-2-phenylacetonitrile|peregrinumcin A

C16H19NO7 (337.1161)


   
   
   

N,O-Didemethylbuchenavianine

N,O-Didemethylbuchenavianine

C20H19NO4 (337.1314)


   

1,4,9-trihydroxynonene mercapturic acid

1,4,9-trihydroxynonene mercapturic acid

C14H27NO6S (337.1559)


   
   

6-Acetyl-7-methoxy-1,2-(methylenedioxy)-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

6-Acetyl-7-methoxy-1,2-(methylenedioxy)-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

C20H19NO4 (337.1314)


   

lankongensisine

lankongensisine

C18H27NO5 (337.1889)


   

(+)-(S)-N-butyrylcaaverine

(+)-(S)-N-butyrylcaaverine

C21H23NO3 (337.1678)


   

3-chloro-8,9-dimethoxygeibalansine

3-chloro-8,9-dimethoxygeibalansine

C17H20ClNO4 (337.1081)


   

N-Demethylcapitavine

N-Demethylcapitavine

C20H19NO4 (337.1314)


   

Dehydroformouregine

Dehydroformouregine

C20H19NO4 (337.1314)


   

Carquinostatin A-59

Carquinostatin A-59

C21H23NO3 (337.1678)


   
   

9-(4-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid

9-(4-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid

C18H27NO5 (337.1889)


   

(6,7-dimethoxy-4-methylisoquinolinyl)-(4-methoxyphenyl)-methanone

(6,7-dimethoxy-4-methylisoquinolinyl)-(4-methoxyphenyl)-methanone

C20H19NO4 (337.1314)


   

(-)-N-acetylxylopine|6-Acetyl-9-methoxy-1,2-methylendioxy-6abeta-aporphan|6-acetyl-9-methoxy-1,2-methylenedioxy-6abeta-aporphane|N-acetylxylopine

(-)-N-acetylxylopine|6-Acetyl-9-methoxy-1,2-methylendioxy-6abeta-aporphan|6-acetyl-9-methoxy-1,2-methylenedioxy-6abeta-aporphane|N-acetylxylopine

C20H19NO4 (337.1314)


   

(-)-phyllostemine|Phyllostemine

(-)-phyllostemine|Phyllostemine

C21H23NO3 (337.1678)


   

5-hydroxy-4,5-dimethyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2h-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3h)-dione

5-hydroxy-4,5-dimethyl-3-(propan-2-yl)-4,5,8,10,12,13,13a,13b-octahydro-2h-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3h)-dione

C18H27NO5 (337.1889)


   

Acronicine epoxide

Acronicine epoxide

C20H19NO4 (337.1314)


   

3alpha-(E)-4-hydroxysenecioyloxy-6beta-angeloyloxytropane

3alpha-(E)-4-hydroxysenecioyloxy-6beta-angeloyloxytropane

C18H27NO5 (337.1889)


   
   
   
   
   
   
   
   

RCS-4 N-(4-hydroxypentyl) metabolite

RCS-4 N-(4-hydroxypentyl) metabolite

C21H23NO3 (337.1678)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

RCS-4 N-(5-hydroxypentyl) metabolite

RCS-4 N-(5-hydroxypentyl) metabolite

C21H23NO3 (337.1678)


   
   

Pseudojatrorrhizine

Pseudojatrorrhizine

C20H19NO4 (337.1314)


   

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)hexan-1-imine

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)hexan-1-imine

C12H23N3O4S2 (337.113)


   

(+)-7-epi-12-oxojasmonoyl-L-isoleucine

(+)-7-epi-12-oxojasmonoyl-L-isoleucine

C18H27NO5 (337.1889)


   

6-O-(indol-3-ylacetyl)-beta-D-glucose

6-O-(indol-3-ylacetyl)-beta-D-glucose

C16H19NO7 (337.1161)


   

Haemanthamine hydrochloride

Haemanthamine hydrochloride

C17H20ClNO4 (337.1081)


   

Olopatadine

Olopatadine

C21H23NO3 (337.1678)


R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D018926 - Anti-Allergic Agents CONFIDENCE standard compound; INTERNAL_ID 2210 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3323

   

Linezolid

Linezolid (Zyvox)

C16H20FN3O4 (337.1438)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3291

   

N2-Isobutyryl-2-deoxyguanosine

N2-Isobutyryl-2-deoxyguanosine

C14H19N5O5 (337.1386)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.589 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.591 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.583 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.587

   
   

Neoplatyphylline

Neoplatyphylline

C18H27NO5 (337.1889)


   

C18H27NO5

NCGC00380837-01_C18H27NO5_

C18H27NO5 (337.1889)


   
   
   
   

9-(4-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid (candicidin related)

9-(4-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid (candicidin related)

C18H27NO5 (337.1889)


   

N2-Isobutyl-deoxyguanosine

N2-Isobutyl-deoxyguanosine

C14H19N5O5 (337.1386)


   

N2-(S)-Propano-deoxyguanosine

N2-(S)-Propano-deoxyguanosine

C14H19N5O5 (337.1386)


   

N2-(R)-Propano-deoxyguanosine

N2-(R)-Propano-deoxyguanosine

C14H19N5O5 (337.1386)


   
   
   
   
   
   
   
   

Desmethylpirenzepine

Desmethylpirenzepine

C18H19N5O2 (337.1539)


   

Dextrorphan sulfate

Dextrorphan sulfate

C17H23NO4S (337.1348)


   
   
   
   
   
   
   
   
   
   
   

Zolpidem Metabolite I

Zolpidem Metabolite I

C19H19N3O3 (337.1426)


   

Zolpidem Metabolite II

Zolpidem Metabolite II

C19H19N3O3 (337.1426)


   

d[-Arg-2]KYOTORPHAN

d[-Arg-2]KYOTORPHAN

C15H23N5O4 (337.175)


   

(S)-cis-N-Methylstylopine

(S)-cis-N-Methylstylopine

C20H19NO4 (337.1314)


   
   

Arg-Tyr

2-[2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C15H23N5O4 (337.175)


A dipeptide formed from L-arginine and L-tyrosine residues.

   

3,6-Ditigloyloxytropan-7-ol

7-hydroxy-8-methyl-3-{[(2E)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2E)-2-methylbut-2-enoate

C18H27NO5 (337.1889)


   

5-Methoxynoracronycine

11-hydroxy-6-methoxy-2,2,5-trimethyl-5,10-dihydro-2H-1-oxa-5-azatetraphen-10-one

C20H19NO4 (337.1314)


   

Junosidine

2,11-Dihydro-5-hydroxy-10-methoxy-2,2,11-trimethyl-6H-pyrano[3,2-b]acridin-6-one, 9ci

C20H19NO4 (337.1314)


   

1H-Indol-3-ylacetyl-myo-inositol

(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-(1H-indol-3-yl)acetate

C16H19NO7 (337.1161)


   

Lambertine

16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(21),2(10),3,8,15,17,19-heptaene

C20H19NO4 (337.1314)


   

4-O-a-D-Galactopyranosylcalystegine b2

4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,3-triol

C13H23NO9 (337.1373)


   

(S)-malyl N-acetyl-alpha-D-glucosaminide

(2S)-2-[(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)oxy]succinic acid;GlcNAc-Mal;alpha-D-GlcNAc-L-Mal;malyl-N-acetyl-D-glucosamine

C12H19NO10 (337.1009)


An N-acetyl-alpha-D-glucosaminide having (S)-malyl as the anomeric substituent.

   

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-FLUOROBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-FLUOROBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C18H24FNO4 (337.1689)


   

(5-amino-1-benzothiophen-2-yl)-(4-phenylpiperazin-1-yl)methanone

(5-amino-1-benzothiophen-2-yl)-(4-phenylpiperazin-1-yl)methanone

C19H19N3OS (337.1249)


   
   
   
   
   

tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4-piperidine]-1-carboxylate

tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4-piperidine]-1-carboxylate

C17H20ClNO4 (337.1081)


   

1H-Indole,2,3-dimethyl-1-[(1,2,4-triazolo[4,3-a]pyrimidin-3-ylthio)acetyl]-(9CI)

1H-Indole,2,3-dimethyl-1-[(1,2,4-triazolo[4,3-a]pyrimidin-3-ylthio)acetyl]-(9CI)

C17H15N5OS (337.0997)


   

Satigrel

4-cyano-5,5-bis(4-methoxyphenyl)pent-4-enoic acid

C20H19NO4 (337.1314)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

4-[3-(4-chloro-6-methoxyquinazolin-7-yl)oxypropyl]morpholine

4-[3-(4-chloro-6-methoxyquinazolin-7-yl)oxypropyl]morpholine

C16H20ClN3O3 (337.1193)


   

methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate

methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate

C15H19N3O4S (337.1096)


   
   

Sodium 4-(nonanoyloxy)benzenesulfonate

Sodium 4-(nonanoyloxy)benzenesulfonate

C15H22NaO5S (337.1086)


   

tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate

tert-butyl-2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-ioxaborolan-2-yl)phenylcarbamate

C17H25BFNO4 (337.1861)


   

Ufenamate

Ufenamate

C18H18F3NO2 (337.129)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one

1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one

C21H23NO3 (337.1678)


   

nifurfoline

nifurfoline

C13H15N5O6 (337.1022)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

   

Fmoc-D-Cyclopropylglycine

Fmoc-D-Cyclopropylglycine

C20H19NO4 (337.1314)


   

Norepinephrine Bitartrate

Norepinephrine Bitartrate

C12H19NO10 (337.1009)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   
   

1-[CARBOXY-(4-METHYLSULFANYL-PHENYL)-METHYL]-PIPERIDINE-3-CARBOXYLICACIDETHYLESTER

1-[CARBOXY-(4-METHYLSULFANYL-PHENYL)-METHYL]-PIPERIDINE-3-CARBOXYLICACIDETHYLESTER

C17H23NO4S (337.1348)


   

L-(-)-NOREPINEPHRINE (+)-BITARTRATE SALT MONOHYDRATE

L-(-)-NOREPINEPHRINE (+)-BITARTRATE SALT MONOHYDRATE

C12H19NO10 (337.1009)


   

Urea, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-N-(4-nitrophenyl)- (9CI)

Urea, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-N-(4-nitrophenyl)- (9CI)

C17H15N5O3 (337.1175)


   

1-[[3-(trifluoromethyl)phenyl]methylamino]cyclohexane-1-carboxylic acid

1-[[3-(trifluoromethyl)phenyl]methylamino]cyclohexane-1-carboxylic acid

C15H19ClF3NO2 (337.1056)


   

2,6-Bis(4-Methylphenyl)-4-phenylpyrylium

2,6-Bis(4-Methylphenyl)-4-phenylpyrylium

C25H21O+ (337.1592)


   

(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

C21H23NO3 (337.1678)


   

1-FMOC-PYRROLIDINE-3-CARBOXYLIC ACID

1-FMOC-PYRROLIDINE-3-CARBOXYLIC ACID

C20H19NO4 (337.1314)


   
   

4-[(4-METHOXYBENZYLIDENE)AMINO]CINNAMIC ACID N-BUTYL ESTER

4-[(4-METHOXYBENZYLIDENE)AMINO]CINNAMIC ACID N-BUTYL ESTER

C21H23NO3 (337.1678)


   

tert-butyl 4-(3-methoxy-4-nitrophenyl)piperazine-1-carboxylate

tert-butyl 4-(3-methoxy-4-nitrophenyl)piperazine-1-carboxylate

C16H23N3O5 (337.1638)


   

Boc-D-glutamic acid α-benzylester

Boc-D-glutamic acid α-benzylester

C17H23NO6 (337.1525)


   

(D-Arg2)-Kyotorphin

(D-Arg2)-Kyotorphin

C15H23N5O4 (337.175)


   

AT7867

4-(4-chlorophenyl)-4-[4-(1H-pyrazol-4-yl)phenyl]piperidine

C20H20ClN3 (337.1346)


AT7867 is a potent ATP-competitive inhibitor of Akt1/Akt2/Akt3 and p70S6K/PKA with IC50s of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively.

   

Olopatadine Methyl Ester

Olopatadine Methyl Ester

C21H23NO3 (337.1678)


   

Boc-β-homo-Asp(OBzl)-OH

Boc-β-homo-Asp(OBzl)-OH

C17H23NO6 (337.1525)


   

2,4-dihydro-5-methyl-4-[(4-methyl-2-nitrophenyl)azo]-2-phenyl-3H-pyrazol-3-one

2,4-dihydro-5-methyl-4-[(4-methyl-2-nitrophenyl)azo]-2-phenyl-3H-pyrazol-3-one

C17H15N5O3 (337.1175)


   

N-Cbz-L-Glutamic acid 5-tert-butyl ester

N-Cbz-L-Glutamic acid 5-tert-butyl ester

C17H23NO6 (337.1525)


   

Boc-L-Glutamic acid 5-benzylester

Boc-L-Glutamic acid 5-benzylester

C17H23NO6 (337.1525)


   

Boc-D-Glutamic acid 5-benzylester

Boc-D-Glutamic acid 5-benzylester

C17H23NO6 (337.1525)


   

Fmoc-L-Cyclopropylglycine

Fmoc-L-Cyclopropylglycine

C20H19NO4 (337.1314)


   

4-(2,2:6,2-TERPYRIDIN-4-YL)BENZALDEHYDE

4-(2,2:6,2-TERPYRIDIN-4-YL)BENZALDEHYDE

C22H15N3O (337.1215)


   

z-β-glu(otbu)-oh

z-β-glu(otbu)-oh

C17H23NO6 (337.1525)


   

(R)-N-Fmoc-Allylglycine

(R)-N-Fmoc-Allylglycine

C20H19NO4 (337.1314)


   

N-(2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)prop-2-enamide

N-(2,5,8,11,14-pentaoxabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)prop-2-enamide

C17H23NO6 (337.1525)


   

N-(4-methoxyphenyl)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanimine

N-(4-methoxyphenyl)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanimine

C20H24BNO3 (337.1849)


   

N-isopentyladenosine

N-isopentyladenosine

C15H23N5O4 (337.175)


   

Z-D-Glu(OtBu)-OH

Z-D-Glu(OtBu)-OH

C17H23NO6 (337.1525)


   

6-O-(N,N-Diisopropylglycyl)hexonic acid

6-O-(N,N-Diisopropylglycyl)hexonic acid

C14H27NO8 (337.1737)


   

H-D-Tyr-Val-Gly-OH

2-[[2-[[2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]acetic acid

C16H23N3O5 (337.1638)


   
   

(4-METHOXY-BENZYLIDENE)-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENYL]-AMINE

(4-METHOXY-BENZYLIDENE)-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENYL]-AMINE

C20H24BNO3 (337.1849)


   

N-benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C20H24BNO3 (337.1849)


   

Fmoc-1-amino-1-cyclobutanecarboxylic acid

Fmoc-1-amino-1-cyclobutanecarboxylic acid

C20H19NO4 (337.1314)


   

Lysergic acid morpholide

Lysergic acid morpholide

C20H23N3O2 (337.179)


   

Pargeverine

2-(dimethylamino)ethyl 2,2-diphenyl-2-prop-2-ynoxyacetate

C21H23NO3 (337.1678)


D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

Fmoc-D-Pro-OH

Fmoc-D-Pro-OH

C20H19NO4 (337.1314)


   

1-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SULFONYL)PYRROLIDINE

1-((4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SULFONYL)PYRROLIDINE

C16H24BNO4S (337.1519)


   

2-Naphthalenol,1-[phenyl[(phenylmethylene)amino]methyl]-

2-Naphthalenol,1-[phenyl[(phenylmethylene)amino]methyl]-

C24H19NO (337.1467)


   

(S)-N-Fmoc-Allylglycine

(S)-N-Fmoc-Allylglycine

C20H19NO4 (337.1314)


   

Benzyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5-carboxylate

Benzyl 1-oxo-3-phenyl-2-oxa-5-azaspiro[3.4]octane-5-carboxylate

C20H19NO4 (337.1314)


   

1-O-tert-butyl 4-O-methyl 2-(phenylmethoxycarbonylamino)butanedioate

1-O-tert-butyl 4-O-methyl 2-(phenylmethoxycarbonylamino)butanedioate

C17H23NO6 (337.1525)


   

Dobutamine hydrochloride

Dobutamine hydrochloride

C18H24ClNO3 (337.1445)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents Dobutamine hydrochloride is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine hydrochloride is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion[1][2][3][4].

   

Oxiperomide

2H-Benzimidazol-2-one,1,3-dihydro-1-[1-(2-phenoxyethyl)-4-piperidinyl]-

C20H23N3O2 (337.179)


C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

Dizocilpine maleate

Dizocilpine maleate

C20H19NO4 (337.1314)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D020011 - Protective Agents Dizocilpine maleate (MK-801 maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes.

   

(S)-methyl 2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylpentanoate

(S)-methyl 2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-4-methylpentanoate

C17H20ClNO4 (337.1081)


   
   

Z-Gly-Gly-Ala-OH

Z-Gly-Gly-Ala-OH

C15H19N3O6 (337.1274)


   
   

(-)-Dizocilpine maleate

(-)-Dizocilpine maleate

C20H19NO4 (337.1314)


   
   

Z-Asp(OtBu)-Ome

Z-Asp(OtBu)-Ome

C17H23NO6 (337.1525)


   

(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate

(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide Dihydrochloride Monohydrate

C14H25Cl2N3O2 (337.1324)


   

5-{[(7-METHYL-2,3-DIHYDRO-1H-INDEN-4-YL)OXY]METHYL}-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL

5-{[(7-METHYL-2,3-DIHYDRO-1H-INDEN-4-YL)OXY]METHYL}-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL

C19H19N3OS (337.1249)


   

(E)-Olopatadine

Olopatadine, (E)-

C21H23NO3 (337.1678)


   

Boc-L-glutamic acid 1-benzyl ester

Boc-L-glutamic acid 1-benzyl ester

C17H23NO6 (337.1525)


   

Phenserine

Phenserine

C20H23N3O2 (337.179)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors

   

(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

C16H21BFNO5 (337.1497)


   

Moxifloxacin Impurity 3

Moxifloxacin Impurity 3

C17H17F2NO4 (337.1126)


   
   

AntioxidantIPPSI

AntioxidantIPPSI

C18H19N5S (337.1361)


   

Fmoc-Cyclopropylglycine

Fmoc-Cyclopropylglycine

C20H19NO4 (337.1314)


   

Voxelotor

Voxelotor

C19H19N3O3 (337.1426)


C78275 - Agent Affecting Blood or Body Fluid B - Blood and blood forming organs D006401 - Hematologic Agents

   

[9-(2-Naphthyl)-9H-carbazol-3-yl]boronic acid

[9-(2-Naphthyl)-9H-carbazol-3-yl]boronic acid

C22H16BNO2 (337.1274)


   

Clenpenterol-D11 hydrochloride

Clenpenterol-D11 hydrochloride

C13H10D11Cl3N2O (337.141)


   

ethyl 2-piperazine-4-cyclopentylethyl thiazole-5-carboxylate

ethyl 2-piperazine-4-cyclopentylethyl thiazole-5-carboxylate

C17H27N3O2S (337.1824)


   

tert-Butyl 4-(5-methoxy-2-nitrophenyl)piperazine-1-carboxylate

tert-Butyl 4-(5-methoxy-2-nitrophenyl)piperazine-1-carboxylate

C16H23N3O5 (337.1638)


   

(-)-Dizocilpine

(-)-Dizocilpine

C20H19NO4 (337.1314)


(-)-Dizocilpine maleate ((-)-MK-801 maleate) is a less active (-)-enantiomer of Dizocilpine. (-)-Dizocilpine maleate is a selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with a Ki of 211.7 nM. (-)-Dizocilpine maleate has antidepressant effects[1][2]. (-)-Dizocilpine maleate ((-)-MK-801 maleate) is a less active (-)-enantiomer of Dizocilpine. (-)-Dizocilpine maleate is a selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with a Ki of 211.7 nM. (-)-Dizocilpine maleate has antidepressant effects[1][2].

   
   

tert-butyl 4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate

tert-butyl 4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate

C13H18F3N3O2S (337.1072)


   

(R)-BoroLeu-(+)-Pinanediol-HCl

(R)-BoroLeu-(+)-Pinanediol-HCl

C14H23BF3NO4 (337.1672)


   

Boc-Tyr(tBu)-OH

Boc-Tyr(tBu)-OH

C18H27NO5 (337.1889)


   

Isoxsuprine hydrochloride

Isoxsuprine hydrochloride

C18H24ClNO3 (337.1445)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 μΜ and 3.48 μΜ for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.

   

AMG 9810

(2E)-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-propenamide

C21H23NO3 (337.1678)


   

N-benzyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-benzyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C20H24BNO3 (337.1849)


   

Tecadenoson

Tecadenoson

C14H19N5O5 (337.1386)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist. Tecadenoson (CVT-510) is a selective A1 adenosine receptor agonist.

   

Posiphen

Posiphen

C20H23N3O2 (337.179)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors C78272 - Agent Affecting Nervous System D004791 - Enzyme Inhibitors

   

6-[(Z)-2-(2,5-dimethoxyphenyl)ethenyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine

6-[(Z)-2-(2,5-dimethoxyphenyl)ethenyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine

C18H19N5O2 (337.1539)


   

Oxymorphone hydrochloride

Oxymorphone hydrochloride

C17H20ClNO4 (337.1081)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

N-(p-Amylcinnamoyl)anthranilic acid

N-(p-Amylcinnamoyl)anthranilic acid

C21H23NO3 (337.1678)


N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker[1][2]. N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is also an effective reversible inhibitor of calcium-activated chloride channels, has potential to treat arrhythmia[3].

   

6-oxo-famciclovir

6-oxo-famciclovir

C14H19N5O5 (337.1386)


   

Butocin

Butocin

C14H19N5O3S (337.1209)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite

   

4-Methylumbelliferylguanidinobenzoate

4-Methylumbelliferylguanidinobenzoate

C18H15N3O4 (337.1063)


   

N4,N6-dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine

N4,N6-dicyclopentyl-2-(methylthio)-5-nitropyrimidine-4,6-diamine

C15H23N5O2S (337.1572)


GS39783 is a positive allosteric modulator (PAM) of GABABR. Positive modulation of the GABABR can be used for the research of Nicotine addiction[1].

   

PF-670462 free base

PF-670462 free base

C19H20FN5 (337.1703)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate

(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate

C18H24ClNO3 (337.1445)


   

1-(2,4-Dimethylphenyl)-4-piperidin-1-ylsulfonylpiperazine

1-(2,4-Dimethylphenyl)-4-piperidin-1-ylsulfonylpiperazine

C17H27N3O2S (337.1824)


   

Bitertanol, (R,R)-(+/-)-

Bitertanol, (R,R)-(+/-)-

C20H23N3O2 (337.179)


   

[4-(Benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone

[4-(Benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone

C16H23N3O3S (337.146)


   

4-methoxy-N-(8-methyl-[1,3]dioxolo[4,5-g]quinazolin-6-yl)benzamide

4-methoxy-N-(8-methyl-[1,3]dioxolo[4,5-g]quinazolin-6-yl)benzamide

C18H15N3O4 (337.1063)


   

N-[(1,2-dimethyl-5-indolyl)methyl]-2-(4-nitrophenyl)acetamide

N-[(1,2-dimethyl-5-indolyl)methyl]-2-(4-nitrophenyl)acetamide

C19H19N3O3 (337.1426)


   

4-[2-(Dimethylamino)ethylamino]-3-benzo[h]quinolinecarboxylic acid ethyl ester

4-[2-(Dimethylamino)ethylamino]-3-benzo[h]quinolinecarboxylic acid ethyl ester

C20H23N3O2 (337.179)


   

N-acetyl-L-tyrosylglycylglycine

N-acetyl-L-tyrosylglycylglycine

C15H19N3O6 (337.1274)


   

Bitertanol, (R,S)-(+/-)-

Bitertanol, (R,S)-(+/-)-

C20H23N3O2 (337.179)


   

3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methylphenyl)propanamide

3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methylphenyl)propanamide

C19H19N3O3 (337.1426)


   

N-[(1,2-dimethyl-5-indolyl)methyl]-2-methyl-3-nitrobenzamide

N-[(1,2-dimethyl-5-indolyl)methyl]-2-methyl-3-nitrobenzamide

C19H19N3O3 (337.1426)


   

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(4-oxo-3-quinazolinyl)acetamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(4-oxo-3-quinazolinyl)acetamide

C18H15N3O4 (337.1063)


   
   
   

(1S,2S)-bitertanol

(1S,2S)-bitertanol

C20H23N3O2 (337.179)


   
   
   

Cyclic 1,N(2)-propanodeoxyguanosine

Cyclic 1,N(2)-propanodeoxyguanosine

C14H19N5O5 (337.1386)


   

2-Piperidinone, 1-[1-oxo-3-[4-(phenylmethoxy)phenyl]propyl]-

2-Piperidinone, 1-[1-oxo-3-[4-(phenylmethoxy)phenyl]propyl]-

C21H23NO3 (337.1678)


   

(2S)-N-[(3Z)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxoimidazolidin-1-YL)phenyl]propanamide

(2S)-N-[(3Z)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxoimidazolidin-1-YL)phenyl]propanamide

C18H19N5O2 (337.1539)


   

Sombrevin

Propanidid

C18H27NO5 (337.1889)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Ractopamine Hydrochloride

Ractopamine Hydrochloride

C18H24ClNO3 (337.1445)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

Oclacitinib

Oclacitinib

C15H23N5O2S (337.1572)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor

   

indole-3-acetyl-beta-4-D-glucose

4,5,6-Trihydroxy-2-(hydroxymethyl)oxan-3-yl 2-(1H-indol-3-yl)acetic acid

C16H19NO7 (337.1161)


Indole-3-acetyl-beta-4-d-glucose belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetyl-beta-4-d-glucose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Indole-3-acetyl-beta-4-d-glucose can be found in a number of food items such as tamarind, black-eyed pea, sweet potato, and sourdough, which makes indole-3-acetyl-beta-4-d-glucose a potential biomarker for the consumption of these food products. Indole-3-acetyl-β-4-d-glucose belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetyl-β-4-d-glucose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Indole-3-acetyl-β-4-d-glucose can be found in a number of food items such as tamarind, black-eyed pea, sweet potato, and sourdough, which makes indole-3-acetyl-β-4-d-glucose a potential biomarker for the consumption of these food products.

   

indole-3-acetyl-beta-6-D-glucose

(3,4,5,6-Tetrahydroxyoxan-2-yl)methyl 2-(1H-indol-3-yl)acetic acid

C16H19NO7 (337.1161)


Indole-3-acetyl-beta-6-d-glucose belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetyl-beta-6-d-glucose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Indole-3-acetyl-beta-6-d-glucose can be found in a number of food items such as apple, coconut, black mulberry, and american butterfish, which makes indole-3-acetyl-beta-6-d-glucose a potential biomarker for the consumption of these food products. Indole-3-acetyl-β-6-d-glucose belongs to indole-3-acetic acid derivatives class of compounds. Those are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. Indole-3-acetyl-β-6-d-glucose is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Indole-3-acetyl-β-6-d-glucose can be found in a number of food items such as apple, coconut, black mulberry, and american butterfish, which makes indole-3-acetyl-β-6-d-glucose a potential biomarker for the consumption of these food products.

   

2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

C20H19NO4 (337.1314)


   

2,3,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-9-one

2,3,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-9-one

C20H19NO4 (337.1314)


   

3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]-N-(3-methylpyridin-2-yl)benzamide

3-[(3,5-dimethyl-1,2-oxazol-4-yl)methoxy]-N-(3-methylpyridin-2-yl)benzamide

C19H19N3O3 (337.1426)


   

indole-3-acetyl-beta-4-D-glucose

indole-3-acetyl-beta-4-D-glucose

C16H19NO7 (337.1161)


   

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 2-(1H-indol-3-yl)acetate

(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 2-(1H-indol-3-yl)acetate

C16H19NO7 (337.1161)


   

1D-1-O-(indol-3-yl)acetyl-myo-inositol

1D-1-O-(indol-3-yl)acetyl-myo-inositol

C16H19NO7 (337.1161)


A cyclitol ester that is 1D-myo-inositol bearing a indol-3-acetyl substituent at position 1.

   

N-beta-D-glucopyranosyl indole-3-acetic acid

N-beta-D-glucopyranosyl indole-3-acetic acid

C16H19NO7 (337.1161)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

6-Prenyl-5,7,4-trihydroxyisoflavone

6-Prenyl-5,7,4-trihydroxyisoflavone

C20H17O5- (337.1076)


   

6-hydroxy-IAA-phenylalanine

6-hydroxy-IAA-phenylalanine

C19H17N2O4- (337.1188)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

indole-3-acetyl-beta-6-D-glucose

indole-3-acetyl-beta-6-D-glucose

C16H19NO7 (337.1161)


   

8-Prenyl-5,7,4-trihydroxyisoflavone

8-Prenyl-5,7,4-trihydroxyisoflavone

C20H17O5- (337.1076)


   

3-prenyl-5,7,4-trihydroxyisoflavone

3-prenyl-5,7,4-trihydroxyisoflavone

C20H17O5- (337.1076)


   

4-O-(indol-3-ylacetyl)-beta-D-glucose

4-O-(indol-3-ylacetyl)-beta-D-glucose

C16H19NO7 (337.1161)


   

Pyrithiamine phosphate

Pyrithiamine phosphate

C14H18N4O4P- (337.1066)


   
   

a Jasmonate-glutamine

a Jasmonate-glutamine

C17H25N2O5- (337.1763)


   

(indol-3-yl)acetyl-L-tyrosine

(indol-3-yl)acetyl-L-tyrosine

C19H17N2O4- (337.1188)


   

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

C20H21N2O3- (337.1552)


   

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,5-diaminopentyl)oxolane-3,4-diol

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,5-diaminopentyl)oxolane-3,4-diol

C14H23N7O3 (337.1862)


   

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[3-(methylamino)propylamino]methyl]oxolane-3,4-diol

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[3-(methylamino)propylamino]methyl]oxolane-3,4-diol

C14H23N7O3 (337.1862)


   

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(5-methylsulfanylpentyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(5-methylsulfanylpentyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

C12H23N3O4S2 (337.113)


   

(2S,3S)-3-methyl-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-5-oxopent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid

(2S,3S)-3-methyl-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-5-oxopent-2-enyl]cyclopentyl]acetyl]amino]pentanoic acid

C18H27NO5 (337.1889)


   
   

Platyphylline

Platyphylline

C18H27NO5 (337.1889)


   

Dichotomide Iii

Dichotomide Iii

C18H15N3O4 (337.1063)


A beta-carboline alkaloid isolated from Stellaria dichotoma var. lanceolata. S

   

Stellarine B

Stellarine B

C18H15N3O4 (337.1063)


A natural product found in Stellaria dichotoma var. lanceolata.

   

5-amino-1-[(3-methoxyphenyl)methyl]-N-(4-methylphenyl)-4-triazolecarboxamide

5-amino-1-[(3-methoxyphenyl)methyl]-N-(4-methylphenyl)-4-triazolecarboxamide

C18H19N5O2 (337.1539)


   

N-(1,4-Dihydroxy-4-methylpentan-2-YL)-3-hydroxy-5-oxo-6-phenylhexanamide

N-(1,4-Dihydroxy-4-methylpentan-2-YL)-3-hydroxy-5-oxo-6-phenylhexanamide

C18H27NO5 (337.1889)


   

Schizanthine O

Schizanthine O

C18H27NO5 (337.1889)


A natural product found in Schizanthus tricolor.

   

Schizanthine N

Schizanthine N

C18H27NO5 (337.1889)


A natural product found in Schizanthus tricolor.

   
   
   

7-Hydroxy-8-(4-morpholinylmethyl)-3-phenyl-1-benzopyran-4-one

7-Hydroxy-8-(4-morpholinylmethyl)-3-phenyl-1-benzopyran-4-one

C20H19NO4 (337.1314)


   

4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide

4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide

C19H19N3O3 (337.1426)


   

2-hydroxy-4-oxo-1-propyl-N-(pyridin-4-ylmethyl)quinoline-3-carboxamide

2-hydroxy-4-oxo-1-propyl-N-(pyridin-4-ylmethyl)quinoline-3-carboxamide

C19H19N3O3 (337.1426)


   

ethyl 3-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-spiro[2-aza-4,7-methanoisoindole-8,1-cyclopropan]-2-yl)benzoate

ethyl 3-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-spiro[2-aza-4,7-methanoisoindole-8,1-cyclopropan]-2-yl)benzoate

C20H19NO4 (337.1314)


   

4-{[4-(4-Methyl-benzyl)-piperazin-1-ylimino]-methyl}-benzoic acid

4-{[4-(4-Methyl-benzyl)-piperazin-1-ylimino]-methyl}-benzoic acid

C20H23N3O2 (337.179)


   

2-amino-4-(2-ethoxyphenyl)-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile

2-amino-4-(2-ethoxyphenyl)-6,7-dimethyl-5-oxo-4H-pyrano[3,2-c]pyridine-3-carbonitrile

C19H19N3O3 (337.1426)


   

1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-3-[3-(dimethylamino)propyl]-1-ethylthiourea

1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-3-[3-(dimethylamino)propyl]-1-ethylthiourea

C17H27N3O2S (337.1824)


   

N-(2-butan-2-ylphenyl)-7-nitro-1H-indole-2-carboxamide

N-(2-butan-2-ylphenyl)-7-nitro-1H-indole-2-carboxamide

C19H19N3O3 (337.1426)


   

2-[[2-(5,6-Dimethyl-1-benzimidazolyl)-1-oxoethyl]amino]benzoic acid methyl ester

2-[[2-(5,6-Dimethyl-1-benzimidazolyl)-1-oxoethyl]amino]benzoic acid methyl ester

C19H19N3O3 (337.1426)


   

1-(2-Furanylmethyl)-3-(2-methylphenyl)-1-(3-pyridinylmethyl)thiourea

1-(2-Furanylmethyl)-3-(2-methylphenyl)-1-(3-pyridinylmethyl)thiourea

C19H19N3OS (337.1249)


   

1-(4-Chlorophenyl)-1-cyclohexyl-3-(4-morpholinyl)-1-propanol

1-(4-Chlorophenyl)-1-cyclohexyl-3-(4-morpholinyl)-1-propanol

C19H28ClNO2 (337.1808)


   

2-(2,4-dimethylanilino)-N-(thiophen-2-ylmethyl)-3-pyridinecarboxamide

2-(2,4-dimethylanilino)-N-(thiophen-2-ylmethyl)-3-pyridinecarboxamide

C19H19N3OS (337.1249)


   

1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide

1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide

C15H19N3O4S (337.1096)


   

9-oxo-N-(3-pyridinylmethyl)-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinoline-8-carboxamide

9-oxo-N-(3-pyridinylmethyl)-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinoline-8-carboxamide

C18H15N3O4 (337.1063)


   

N-(2-methoxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-(2-methoxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C19H19N3O3 (337.1426)


   

[3-[3-(5-Methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone

[3-[3-(5-Methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-phenylmethanone

C19H19N3O3 (337.1426)


   

N-[(2S)-1-hydroxypropan-2-yl]-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-[(2S)-1-hydroxypropan-2-yl]-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C19H19N3O3 (337.1426)


   

(1Z)-1-[(5S)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}-2,4-dioxopyrrolidin-3-ylidene]ethanolate

(1Z)-1-[(5S)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}-2,4-dioxopyrrolidin-3-ylidene]ethanolate

C20H21N2O3- (337.1552)


   

5-(2-Chloro-6-fluorobenzyl)-6-methyl-2-morpholinopyrimidin-4-ol

5-(2-Chloro-6-fluorobenzyl)-6-methyl-2-morpholinopyrimidin-4-ol

C16H17ClFN3O2 (337.0993)


   

ethyl N-acetylneuraminate

ethyl N-acetylneuraminate

C13H23NO9 (337.1373)


   
   
   
   
   
   
   
   
   
   
   

1L-1-O-(indol-3-yl)acetyl-myo-inositol

1L-1-O-(indol-3-yl)acetyl-myo-inositol

C16H19NO7 (337.1161)


   

indole-3-acetyl-N-beta-D-glucose

indole-3-acetyl-N-beta-D-glucose

C16H19NO7 (337.1161)


   

4-[2-[[(4-Fluorophenyl)-oxomethyl]amino]ethylamino]-1-piperidinecarboxylic acid ethyl ester

4-[2-[[(4-Fluorophenyl)-oxomethyl]amino]ethylamino]-1-piperidinecarboxylic acid ethyl ester

C17H24FN3O3 (337.1802)


   

N-[2-(diethylamino)ethyl]-2-(2-furanyl)-4-quinolinecarboxamide

N-[2-(diethylamino)ethyl]-2-(2-furanyl)-4-quinolinecarboxamide

C20H23N3O2 (337.179)


   

4-[2-[[(3-Fluorophenyl)-oxomethyl]amino]ethylamino]-1-piperidinecarboxylic acid ethyl ester

4-[2-[[(3-Fluorophenyl)-oxomethyl]amino]ethylamino]-1-piperidinecarboxylic acid ethyl ester

C17H24FN3O3 (337.1802)


   

N-[2-(3,4-dihydroxyphenyl)ethyl]-4-(4-hydroxyphenyl)butan-2-aminium chloride

N-[2-(3,4-dihydroxyphenyl)ethyl]-4-(4-hydroxyphenyl)butan-2-aminium chloride

C18H24ClNO3 (337.1445)


   

(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2S,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2S,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2R,3R,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

(2R,3R,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

C19H19N3O3 (337.1426)


   

(2R,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2R,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2R,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

(2R,3S,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenylazetidine-1-carboxamide

C19H19N3O3 (337.1426)


   

3-(allylsulfanyl)-4-[4-(benzyloxy)phenyl]-5-methyl-4H-1,2,4-triazole

3-(allylsulfanyl)-4-[4-(benzyloxy)phenyl]-5-methyl-4H-1,2,4-triazole

C19H19N3OS (337.1249)


   

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2R,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2R,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2S,3S,4S)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide

C15H19N3O4S (337.1096)


   

(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-[4-(3-pyridinyl)phenyl]-2-azetidinecarbonitrile

C19H19N3O3 (337.1426)


   

(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

(2S,3R,4R)-2-cyano-4-(hydroxymethyl)-N-(2-methoxyphenyl)-3-phenyl-1-azetidinecarboxamide

C19H19N3O3 (337.1426)


   

Methyl (2E,3E,5E,7E)-13-amino-2-ethylidene-11,12-dihydroxy-4,10-dimethyl-13-oxotrideca-3,5,7-trienoate

Methyl (2E,3E,5E,7E)-13-amino-2-ethylidene-11,12-dihydroxy-4,10-dimethyl-13-oxotrideca-3,5,7-trienoate

C18H27NO5 (337.1889)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

beta-D-Tyvp-(1->3)-beta-D-GalpN6,OMe2

beta-D-Tyvp-(1->3)-beta-D-GalpN6,OMe2

C14H27NO8 (337.1737)


   

N-hydroxy-N-[(E)-[(2S,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

N-hydroxy-N-[(E)-[(2S,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

C12H23N3O8 (337.1485)


   

N-hydroxy-N-[(E)-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

N-hydroxy-N-[(E)-[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexylidene]amino]hexanediamide

C12H23N3O8 (337.1485)


   

Nonanal O-[(pentafluorophenyl)methyl]oxime

Nonanal O-[(pentafluorophenyl)methyl]oxime

C16H20F5NO (337.1465)


   

1-Acetoxy-3-(N-acetyl-2-acetoxyethylamino)-5-methoxy-2,6-dimethylbenzene

1-Acetoxy-3-(N-acetyl-2-acetoxyethylamino)-5-methoxy-2,6-dimethylbenzene

C17H23NO6 (337.1525)


   

N-Trimethylsilylphenylacetylglycine trimethylsilyl ester

N-Trimethylsilylphenylacetylglycine trimethylsilyl ester

C16H27NO3Si2 (337.1529)


   

Kyotorphin

Kyotorphin acetate salt

C15H23N5O4 (337.175)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004723 - Endorphins Kyotorphin is an endogenou neuroactive dipeptide with analgesic properties. Kyotorphin possesses anti-inflammatory and antimicrobial activity. Kyotorphin levels in cerebro-spinal fluid correlate negatively with the progression of neurodegeneration in Alzheimer's Disease patients[1].

   

1-O-indol-3-Ylacetyl-beta-D-glucose

1-O-indol-3-Ylacetyl-beta-D-glucose

C16H19NO7 (337.1161)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   
   

ZM 241385

4-(2-((7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino)ethyl)phenol

C16H15N7O2 (337.1287)


ZM241385 is a potent, high affinity and selective adenosine A2a receptor (A2AR) antagonist with a Ki value of 1.4 nM[1][2][3].

   

tyrosylarginine

tyrosylarginine

C15H23N5O4 (337.175)


   

4-O-alpha-D-Galactopyranosylcalystegine B2

4-O-alpha-D-Galactopyranosylcalystegine B2

C13H23NO9 (337.1373)


   

N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide

N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide

C16H20FN3O4 (337.1438)


   

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

(3Z,5S)-3-(1-oxidoethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione(1-)

C20H21N2O3 (337.1552)


Conjugate base of (3Z,5S)-3-(1-hydroxyethylidene)-5-{[4-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}pyrrolidine-2,4-dione arising from deprotonation of the enolic hydroxy group; major species at pH 7.3.

   

1-O-(indol-3-ylacetyl)-beta-D-glucose

1-O-(indol-3-ylacetyl)-beta-D-glucose

C16H19NO7 (337.1161)


   
   
   

AMPK activator 2 (hydrochloride)

AMPK activator 2 (hydrochloride)

C13H19ClF3N5 (337.1281)


AMPK activator 2 (compound 7a) hydrochloride, a fluorine-containing proguanil derivative, up-regulates AMPK signal pathway and downregulates mTOR/4EBP1/p70S6K. AMPK activator 2 hydrochloride inhibits proliferation and migration of human cancer cell lines (UMUC3, T24, A549)[1].

   

ISAM-140

ISAM-140

C19H19N3O3 (337.1426)


ISAM-140 (22b) is a potent and highly selective A2B adenosine receptor antagonist with a Ki of 3.49 nM[1].

   

Phox-I2

Phox-I2

C18H15N3O4 (337.1063)


Phox-I2 is a selective inhibitor of p67phox-Rac1 interaction, binds to p67phox with high affinity with a Kd of ~150 nM. Phox-I2 is a NADPH oxidase 2 (NOX2) inhibitor and inhibits reactive oxygen species (ROS) production[1].

   

S1RA

S1RA

C20H23N3O2 (337.179)


S1RA (E-52862) is a highly selective σ1 receptor (σ1R) antagonist with Kis of 17 nM and 23.5 nM for human σ1R and guinea pig σ1R, respectively. S1RA has Moderate antagonistic activity for human 5-HT2B receptor (Ki= 328 nM). S1RA has antinociceptive effects in neuropathic pain models. S1RA prevents mechanical and cold hypersensitivity in Oxaliplatin (HY-17371)-treated mice[1][2].

   

3-hydroxy-4-methyl-3'-(4-methyl-5-oxooxolan-2-yl)-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

3-hydroxy-4-methyl-3'-(4-methyl-5-oxooxolan-2-yl)-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

C18H27NO5 (337.1889)


   

{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl acetate

{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl acetate

C16H19NO7 (337.1161)


   

(1r,2r,3r,4s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl 2-(1h-indol-3-yl)acetate

(1r,2r,3r,4s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl 2-(1h-indol-3-yl)acetate

C16H19NO7 (337.1161)


   

2,3,4,5,6-pentahydroxycyclohexyl 2-(1h-indol-2-yl)acetate

2,3,4,5,6-pentahydroxycyclohexyl 2-(1h-indol-2-yl)acetate

C16H19NO7 (337.1161)


   

10-hydroxy-12-methoxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one

10-hydroxy-12-methoxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one

C20H19NO4 (337.1314)


   

6,7-dimethoxy-1-(4-methoxybenzoyl)-4-methylisoquinoline

6,7-dimethoxy-1-(4-methoxybenzoyl)-4-methylisoquinoline

C20H19NO4 (337.1314)


   

methyl 3-({1-acetyl-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

methyl 3-({1-acetyl-9h-pyrido[3,4-b]indol-3-yl}formamido)prop-2-enoate

C18H15N3O4 (337.1063)


   

(1s,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

(1s,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

methyl 3-(4-hydroxyphenyl)-2-methoxy-2-(3-methyl-2-oxobutanamido)-3-oxopropanoate

methyl 3-(4-hydroxyphenyl)-2-methoxy-2-(3-methyl-2-oxobutanamido)-3-oxopropanoate

C16H19NO7 (337.1161)


   

{1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]indol-3-yl}acetic acid

{1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]indol-3-yl}acetic acid

C16H19NO7 (337.1161)


   

1-[(1s,2r)-1-amino-2-{[(1r,2s)-2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl]pyridin-4-one

1-[(1s,2r)-1-amino-2-{[(1r,2s)-2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl]pyridin-4-one

C14H19N5O5 (337.1386)


   

atalaphyllidine; 11,12-n,o-di-me

NA

C20H19NO4 (337.1314)


{"Ingredient_id": "HBIN017269","Ingredient_name": "atalaphyllidine; 11,12-n,o-di-me","Alias": "NA","Ingredient_formula": "C20H19NO4","Ingredient_Smile": "NA","Ingredient_weight": "337.37","OB_score": "NA","CAS_id": "51179-68-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6507","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,2s,3r,5s,6r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

(1r,2s,3r,5s,6r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

C13H23NO9 (337.1373)


   

(9s)-10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

(9s)-10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

C20H19NO4 (337.1314)


   

1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]butan-1-one

1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]butan-1-one

C21H23NO3 (337.1678)


   

4-[(8ar)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-7-yl]-2-methoxyphenol

4-[(8ar)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-7-yl]-2-methoxyphenol

C21H23NO3 (337.1678)


   

2-[(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]amino}-1-hydroxypropylidene)amino]benzoic acid

2-[(2-{[1-carboxy-3-(c-hydroxycarbonimidoyl)propyl]amino}-1-hydroxypropylidene)amino]benzoic acid

C15H19N3O6 (337.1274)


   

1-[(12r)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

1-[(12r)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

C20H19NO4 (337.1314)


   

(1r,2r,3s,4s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl 2-(1h-indol-2-yl)acetate

(1r,2r,3s,4s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl 2-(1h-indol-2-yl)acetate

C16H19NO7 (337.1161)


   

1-[(12s,13r)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

1-[(12s,13r)-13-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl]ethanone

C20H19NO4 (337.1314)


   

4-[6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-7-yl]-2-methoxyphenol

4-[6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-7-yl]-2-methoxyphenol

C21H23NO3 (337.1678)


   

16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

16,17-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C20H19NO4 (337.1314)


   

15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene

C20H19NO4 (337.1314)


   

1-{2-[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]indol-1-yl}ethanone

1-{2-[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]indol-1-yl}ethanone

C16H19NO7 (337.1161)


   

17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

C20H19NO4 (337.1314)


   

(17s)-17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

(17s)-17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19)-hexaen-18-one

C20H19NO4 (337.1314)


   

10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

10-acetyl-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-8-one

C20H19NO4 (337.1314)


   

(2r,3s,4s,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl 2-(1h-indol-3-yl)acetate

(2r,3s,4s,5r,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl 2-(1h-indol-3-yl)acetate

C16H19NO7 (337.1161)


   

(3s)-2-acetyl-3-(1-methylhydrazin-1-yl)butanedioic acid; oxindole

(3s)-2-acetyl-3-(1-methylhydrazin-1-yl)butanedioic acid; oxindole

C15H19N3O6 (337.1274)


   

1-[(2r)-2-hydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

1-[(2r)-2-hydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

C21H23NO3 (337.1678)


   

1-{16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

1-{16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

C20H19NO4 (337.1314)


   

1-(2-hydroxypropyl)-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

1-(2-hydroxypropyl)-2-methyl-6-(3-methylbut-2-en-1-yl)-9h-carbazole-3,4-dione

C21H23NO3 (337.1678)


   

4-ethylidene-7-hydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

4-ethylidene-7-hydroxy-7-methyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-3,6,8-trione

C17H23NO6 (337.1525)


   

3,4,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

3,4,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

C20H19NO4 (337.1314)


   

14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-10-carbaldehyde

14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene-10-carbaldehyde

C20H19NO4 (337.1314)


   

{1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]indol-3-yl}acetic acid

{1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]indol-3-yl}acetic acid

C16H19NO7 (337.1161)


   

(1s,24r)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

(1s,24r)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

1-{17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

1-{17-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-yl}ethanone

C20H19NO4 (337.1314)


   

14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaene-5,16-diol

14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaene-5,16-diol

C20H19NO4 (337.1314)


   

{9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl}methyl acetate

{9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl}methyl acetate

C20H19NO4 (337.1314)


   

3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

C17H23NO4S (337.1348)


   

24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

1-[(12r)-7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

1-[(12r)-7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

C20H19NO4 (337.1314)


   

1-{7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone

1-{7-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone

C20H19NO4 (337.1314)


   

(1r,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

(1r,24s)-24-methyl-5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15,20,22-hexaene

C20H19NO4 (337.1314)


   

18,19-dimethoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(20),2(10),3,8,11,16,18-heptaene

18,19-dimethoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(20),2(10),3,8,11,16,18-heptaene

C20H19NO4 (337.1314)


   

16-hydroxy-14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,3,6,9(17),11,13,15-heptaen-5-one

16-hydroxy-14,15-dimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1,3,6,9(17),11,13,15-heptaen-5-one

C20H19NO4 (337.1314)


   

(2e)-3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

(2e)-3-methanesulfonyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enimidic acid

C17H23NO4S (337.1348)


   

3-[(2z)-4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene]-2-methylpropanimidic acid

3-[(2z)-4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene]-2-methylpropanimidic acid

C17H23NO6 (337.1525)


   

2,3,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

2,3,11-trimethoxy-7,8-dihydro-6-azatetraphen-10-one

C20H19NO4 (337.1314)


   

[(3r)-9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl]methyl acetate

[(3r)-9-hydroxy-3,5-dimethyl-11h-pyrano[3,2-a]carbazol-3-yl]methyl acetate

C20H19NO4 (337.1314)


   

5,7-dihydroxy-2-phenyl-6-(piperidin-2-yl)chromen-4-one

5,7-dihydroxy-2-phenyl-6-(piperidin-2-yl)chromen-4-one

C20H19NO4 (337.1314)


   

1-(1-amino-2-{[2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl)pyridin-4-one

1-(1-amino-2-{[2-amino-1-hydroxy-2-(4-oxopyridin-1-yl)ethyl](hydroxy)amino}-2-hydroxyethyl)pyridin-4-one

C14H19N5O5 (337.1386)


   

[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate

[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C16H19NO7 (337.1161)


   

1-(2-{[(1r,2r,3s,4s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}indol-1-yl)ethanone

1-(2-{[(1r,2r,3s,4s,5r,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}indol-1-yl)ethanone

C16H19NO7 (337.1161)


   

3-(4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene)-2-methylpropanimidic acid

3-(4-{4-[(acetyloxy)methyl]-4-hydroxycyclohexyl}-5-oxofuran-2-ylidene)-2-methylpropanimidic acid

C17H23NO6 (337.1525)


   

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-2-one

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-2-one

C20H19NO4 (337.1314)


   

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-8-azabicyclo[3.2.1]octane-1,2,6-triol

C13H23NO9 (337.1373)


   

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-4-one

3,10,11-trimethoxy-7,8-dihydro-6-azatetraphen-4-one

C20H19NO4 (337.1314)


   

methyl (2r)-3-(4-hydroxyphenyl)-2-methoxy-2-(3-methyl-2-oxobutanamido)-3-oxopropanoate

methyl (2r)-3-(4-hydroxyphenyl)-2-methoxy-2-(3-methyl-2-oxobutanamido)-3-oxopropanoate

C16H19NO7 (337.1161)